MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 11:02 Uhr</div>Hello! This post was created with XRumer 23 StrongAI. Good luck :) https://basket.com.ua/ [url=https://tsn.ua/ru ]Basketball3[/url] variant1 [url=]Zoya Demidenko[/url]: Scholar in Oncology Science [url=]Zoya Demidenko[/url] is a recognized investigator connected with the Department of Cell Stress Research at Roswell Park Oncology Institute in Buffalo, New York. Previously, she was employed at the National Institutes of Health and New York Medical College, establishing a robust base in life science study. Her academic contributions encompasses several pivotal areas, including the PI3K/AKT/mTOR molecular pathway, cellular cycle regulation, cellular aging, and cancer biology. To date, she has written more than 46 academic papers, which have received upwards of 4,100 references — a reflection to the influence of her work. One of her key achievements lies in understanding the pathways of cellular senescence. Her studies showed that when the cell cycle is arrested yet cellular growth proceeds, the cells undergo senescence. Importantly, [url=]Zoya Demidenko[/url] showed that this process can be inhibited by medication using substances such as mTOR inhibitors. [url=]Zoya Demidenko[/url] has also brought considerably to tumor management research, particularly in the area of cyclotherapy — a method intended to shielding normal cells from cytotoxic treatment whilst leaving cancer cells susceptible. This method offers considerable potential for diminishing the side effects of cancer treatment. Throughout her professional journey, Demidenko has collaborated with prominent investigators internationally, among them Dr. Mikhail Blagosklonny. Her publications can be found in top-tier publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.</blockquote><br> Abbrechen
